Free Trial

Evoke (LON:EVOK) Shares Down 10% - Time to Sell?

Evoke logo with Consumer Cyclical background
Remove Ads

Evoke plc (LON:EVOK - Get Free Report) traded down 10% on Thursday . The stock traded as low as GBX 50.20 ($0.65) and last traded at GBX 51.73 ($0.67). Approximately 65,066,164 shares were traded during trading, an increase of 1,994% from the average session volume of 3,107,171 shares. The stock had previously closed at GBX 57.45 ($0.74).

Wall Street Analysts Forecast Growth

EVOK has been the topic of a number of analyst reports. Berenberg Bank lowered their price objective on Evoke from GBX 130 ($1.68) to GBX 90 ($1.16) and set a "buy" rating on the stock in a report on Wednesday, December 4th. Jefferies Financial Group reissued a "buy" rating and set a GBX 140 ($1.81) target price on shares of Evoke in a research report on Monday, December 16th.

Read Our Latest Analysis on EVOK

Evoke Stock Down 5.3 %

The firm has a fifty day moving average price of GBX 68.36 and a 200 day moving average price of GBX 63.39. The company has a market cap of £211.75 million, a P/E ratio of -1.19 and a beta of 0.84.

Evoke (LON:EVOK - Get Free Report) last announced its earnings results on Wednesday, March 26th. The company reported GBX (6.40) (($0.08)) earnings per share for the quarter. Evoke had a negative return on equity of 517.98% and a negative net margin of 8.50%. On average, sell-side analysts anticipate that Evoke plc will post 12.7648305 earnings per share for the current year.

Insider Transactions at Evoke

In other Evoke news, insider Andrea Gisle Joosen purchased 14,572 shares of the stock in a transaction dated Tuesday, January 28th. The stock was bought at an average price of GBX 70 ($0.90) per share, for a total transaction of £10,200.40 ($13,178.81). 27.00% of the stock is currently owned by corporate insiders.

Evoke Company Profile

(Get Free Report)

Recommended Stories

Should You Invest $1,000 in Evoke Right Now?

Before you consider Evoke, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Evoke wasn't on the list.

While Evoke currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

Recent Videos

3 Stocks to Buy on the Dip—and 3 to Dump Fast
Trump Tariffs Tumble the Stock Market—Here’s How to Protect Your Money
Donald Trump Owns These 7 Stocks, Should You?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads